PharmaLot, written by Ed Silverman, one of the best blog sources for news and views about the pharmaceutical industry and related issues, is back in operation.
Thursday, May 21, 2015
BLOGSCAN - PharmaLot is Back
Related Articles with BLOGSCAN - PharmaLot is Back :
Pharmacy Benefit Managers as Pharmaceutical MarketersWe posted a number of times about questionable practices Eli Lilly used to market its atypical anti-psychotic drug Zyprexa (olanz ...
Green Ketchup for Novartis?We recently commented on the challenges facing the large, Swiss based multinational pharmaceutical company Novartis. From B ...
Merck Settles Another Vioxx CaseAll the shenanigans that went on in the course of Merck's marketing of the now withdrawn Cox-2 inhibitor non-steroidal anti-infla ...
Medical Informatics, Pharma, Health IT, and Golden Advice That Sits Sadly UnusedIn recent correspondences with colleagues I was reminded of a letter I wrote seven years ago that was published in Bio-IT World, ...
How Industry Views the Research It SponsorsWe have posted frequently about threats to the integrity of the clinical evidence-based, and to the practice of evidence-based me ...
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment